Movement Alert｜PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed

Market Focus06-26

On June 26, PegBio Pharmaceutical-B declined 8.19% in regular trading, trading at HK$5.25 per share, with turnover of approximately HK$41.46 million.

On the news front, the company announced the completion of its H-share full circulation. Approximately 101.7 million non-listed shares were converted into H shares on June 25, and began trading on the Hong Kong Stock Exchange at 9:00 a.m. on June 26. Following the conversion, the number of H shares increased from 284.3 million to 386.0 million, raising the H-share proportion from 72.69% to 98.70% of total issued shares. Non-listed shares dropped sharply from 106.8 million to just 5.09 million, representing only 1.30% of total capital. The concentrated release of previously restricted shares into the open market significantly expanded tradable supply, creating substantial short-term selling pressure on the stock price.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158003214?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 13:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158003214","market":"hk","top_or_hot":-1,"title":"Movement Alert｜PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed","media":"Market Focus","content":"<p><p>On June 26, PegBio Pharmaceutical-B declined 8.19% in regular trading, trading at HK$5.25 per share, with turnover of approximately HK$41.46 million.</p><p>On the news front, the company announced the completion of its H-share full circulation. Approximately 101.7 million non-listed shares were converted into H shares on June 25, and began trading on the Hong Kong Stock Exchange at 9:00 a.m. on June 26. Following the conversion, the number of H shares increased from 284.3 million to 386.0 million, raising the H-share proportion from 72.69% to 98.70% of total issued shares. Non-listed shares dropped sharply from 106.8 million to just 5.09 million, representing only 1.30% of total capital. The concentrated release of previously restricted shares into the open market significantly expanded tradable supply, creating substantial short-term selling pressure on the stock price.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-26 13:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 26, PegBio Pharmaceutical-B declined 8.19% in regular trading, trading at HK$5.25 per share, with turnover of approximately HK$41.46 million.</p><p>On the news front, the company announced the completion of its H-share full circulation. Approximately 101.7 million non-listed shares were converted into H shares on June 25, and began trading on the Hong Kong Stock Exchange at 9:00 a.m. on June 26. Following the conversion, the number of H shares increased from 284.3 million to 386.0 million, raising the H-share proportion from 72.69% to 98.70% of total issued shares. Non-listed shares dropped sharply from 106.8 million to just 5.09 million, representing only 1.30% of total capital. The concentrated release of previously restricted shares into the open market significantly expanded tradable supply, creating substantial short-term selling pressure on the stock price.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02565","symbol_name":"派格生物医药-B","start_time":0,"source_url":"","article_id":"1158003214","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158003214","pubTimestamp":1782452479,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 26, PegBio Pharmaceutical-B declined 8.19% in regular trading, trading at HK$5.25 per share, with turnover of approximately HK$41.46 million.On the news front, the company announced the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02565":"派格生物医药-B"},"translate_title":"动静快讯|派格生物制药-B常规交易跌8.19%H股全流通完成新上市超1亿股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02565":1},"content_text":"On June 26, PegBio Pharmaceutical-B declined 8.19% in regular trading, trading at HK$5.25 per share, with turnover of approximately HK$41.46 million.On the news front, the company announced the completion of its H-share full circulation. Approximately 101.7 million non-listed shares were converted into H shares on June 25, and began trading on the Hong Kong Stock Exchange at 9:00 a.m. on June 26. Following the conversion, the number of H shares increased from 284.3 million to 386.0 million, raising the H-share proportion from 72.69% to 98.70% of total issued shares. Non-listed shares dropped sharply from 106.8 million to just 5.09 million, representing only 1.30% of total capital. The concentrated release of previously restricted shares into the open market significantly expanded tradable supply, creating substantial short-term selling pressure on the stock price.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158003214","isCrawlerRequest":true}